A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
Martin Kulke,Felix Nagel,Lukas Schulig,Norman Geist,Marcel Gabor,Julia Mayerle,Markus M Lerch,Andreas Link,Mihaela Delcea
DOI: https://doi.org/10.2147/JIR.S304787
IF: 4.5
2021-05-22
Journal of Inflammation Research
Abstract:Martin Kulke, 1 Felix Nagel, 1 Lukas Schulig, 2 Norman Geist, 1 Marcel Gabor, 1 Julia Mayerle, 3 Markus M Lerch, 4 Andreas Link, 2 Mihaela Delcea 1 1 Institute of Biochemistry, University of Greifswald, Greifswald, Germany; 2 Institute of Pharmacy, University of Greifswald, Greifswald, Germany; 3 Department of Medicine II, Ludwig-Maximilian University of Munich, Munich, Germany; 4 Department of Medicine a, University Medicine Greifswald, Greifswald, Germany Correspondence: Mihaela Delcea; Martin Kulke Institute of Biochemistry, University of Greifswald, Felix-Hausdorff-Straße 4, Greifswald, 17487, Germany Tel +49 3834 420 4423 Fax +49 3834 420 4377 Email ; Purpose: Although strongly related, the pathophysiological effect of the N34S mutation in the serine protease inhibitor Kazal type 1 (SPINK1) in chronic pancreatitis is still unknown. In this study, we investigate the conformational space of the human cationic trypsin-serine protease inhibitor complex. Methods: Simulations with molecular dynamics, replica exchange, and transition pathway methods are used. Results: Two main binding states of the inhibitor to the complex were found, which explicitly relate the influence of the mutation site to conformational changes in the active site of trypsin. Conclusion: Based on our result, a hypothesis is formulated that explains the development of chronic pancreatitis through accelerated digestion of the mutant by trypsin. Keywords: trypsin, molecular dynamics simulations, replica exchange, transition path sampling, umbrella sampling Pancreatitis is an inflammatory disorder of the pancreas. While acute and chronic pancreatitis were previously viewed as separated diseases, today they are regarded as a continuum, with nearly 30% of the patients exhibiting overlapping phenotypes that manifest as recurrent pancreatitis. 1 Chronic pancreatitis (CP) develops from recurrent episodes of acute pancreatitis that lead to fibrosis, exocrine pancreatic insufficiency and diabetes. While initial triggers for pancreatitis are diverse, almost all of them result in premature activation of trypsin and subsequently other proteases in pancreatic acinar cells. Therefore, pancreatitis is considered to be an autodigestive disorder caused by trypsin auto-activation, which is also supported by numerous mutations in the PRSS1 gene coding for human cationic trypsin (TRY1). 2 , 3 The serine protease inhibitor Kazal-type 1 (SPINK1, also known as PSTI or TATI) represents the first line of defense against the trypsin auto-activation cascade by potently binding and inhibiting active trypsin. The inhibitor has a size of 6.2 kDa and is co-located with trypsinogen and other zymogens in storage organelles called zymogen granules of pancreatic acinar cells. The c.101A>G point mutation is the most common variant of the SPINK1 gene, which results in a p.N34S amino acid substitution and represents one of the most clinically relevant risk factors for chronic pancreatitis with almost 10% of the patients carrying the mutation, compared to 1% of the healthy population. 4–6 Although the p.N34S mutation was identified over two decades ago and was subjected to many additional studies, the mechanism of action of this variant remains enigmatic to this day. 4 , 5 , 7 , 8 Hypotheses regarding the disease relevant function of this variant ranged from reduced inhibitory activity, misfolding, reduced expression or secretion to reduced proteolytic stability, structural alterations and secondary trigger mechanisms. While most of the aforementioned hypotheses have now been refuted, very little is known about the SPINK1 structure. 9–16 Patient studies revealed that the p.N34S mutation alone is not sufficient to develop chronic pancreatitis, but must be combined with additional risk factors. 17–19 It can therefore be assumed that the p.N34S mutation does not lead to a complete destruction of functional SPINK1, but rather reduces either the kinetic properties or the number of correctly folded SPINK1 molecules. In an earlier study, we showed differing secondary structures of SPINK1 wild type (WT) and the N34S mutant by circular dichroism (CD) spectroscopy as well as different secondary structures at lower pH values. 20 </s -Abstract Truncated-
immunology